ArticleFrontiers in pharmacology2024

Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells

Cailan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.